P

Inventor

STURDIVANT JILL MARIE

US39 patents
⚠️ This page may combine multiple inventors who share the name “STURDIVANT JILL MARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AERIE PHARMACEUTICALS INC

30 patents
US9415043B2Aug 16, 2016

Combination therapy

AERIE PHARMACEUTICALS INC32 citations98
US9096569B2Aug 4, 2015

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

AERIE PHARMACEUTICALS INC40 citations98
US8921392B2Dec 30, 2014

6-aminoisoquinoline compounds

AERIE PHARMACEUTICALS INC38 citations98
US8716310B2May 6, 2014

Dual mechanism inhibitors for the treatment of disease

AERIE PHARMACEUTICALS INC49 citations98
US8357699B2Jan 22, 2013

6-aminoisoquinoline compounds

AERIE PHARMACEUTICALS INC42 citations98
US8034943B2Oct 11, 2011

6-aminoisoquinoline compounds

AERIE PHARMACEUTICALS INC49 citations98
US7671205B2Mar 2, 2010

6-aminoisoquinoline compounds

AERIE PHARMACEUTICALS INC61 citations98
US10899714B2Jan 26, 2021

6-aminoisoquinoline compounds

AERIE PHARMACEUTICALS INC10 citations94
US10882840B2Jan 5, 2021

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

AERIE PHARMACEUTICALS INC10 citations94
US10654844B2May 19, 2020

Dual mechanism inhibitors for the treatment of disease

AERIE PHARMACEUTICALS INC11 citations94
US10112920B2Oct 30, 2018

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

AERIE PHARMACEUTICALS INC20 citations94
US9884840B2Feb 6, 2018

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

AERIE PHARMACEUTICALS INC25 citations94
US10532993B2Jan 14, 2020

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

AERIE PHARMACEUTICALS INC9 citations93
US9951059B2Apr 24, 2018

Dual mechanism inhibitors for the treatment of disease

AERIE PHARMACEUTICALS INC10 citations93
US10588901B2Mar 17, 2020

Combination therapy

AERIE PHARMACEUTICALS INC9 citations92
US9993470B2Jun 12, 2018

Combination therapy

AERIE PHARMACEUTICALS INC13 citations92
US9931336B2Apr 3, 2018

Combination therapy

AERIE PHARMACEUTICALS INC11 citations92
US9365518B2Jun 14, 2016

6-aminoisoquinoline compounds

AERIE PHARMACEUTICALS INC10 citations92
US11197853B2Dec 14, 2021

Combination therapy

AERIE PHARMACEUTICALS INC5 citations84
US11185538B2Nov 30, 2021

Compositions for treating glaucoma or reducing intraocular pressure

AERIE PHARMACEUTICALS INC5 citations84
US11028081B2Jun 8, 2021

Dual mechanism inhibitors for the treatment of disease

AERIE PHARMACEUTICALS INC6 citations84
US11020385B2Jun 1, 2021

Combination therapy

AERIE PHARMACEUTICALS INC7 citations84
US11021456B2Jun 1, 2021

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

AERIE PHARMACEUTICALS INC5 citations84
US10568878B2Feb 25, 2020

Combination therapy

AERIE PHARMACEUTICALS INC6 citations84
US10472327B2Nov 12, 2019

6-aminoisoquinoline compounds

AERIE PHARMACEUTICALS INC6 citations84
US9890123B2Feb 13, 2018

6-aminoisoquinoline compounds

AERIE PHARMACEUTICALS INC5 citations84
US9849122B2Dec 26, 2017

Combination therapy

AERIE PHARMACEUTICALS INC7 citations84
US9512101B2Dec 6, 2016

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

AERIE PHARMACEUTICALS INC6 citations84
US11618748B2Apr 4, 2023

Dual mechanism inhibitors for the treatment of disease

AERIE PHARMACEUTICALS INC1 citations73
US10550087B2Feb 4, 2020

Process for the preparation of kinase inhibitors and intermediates thereof

AERIE PHARMACEUTICALS INC1 citations61

DELONG MITCHELL A

9 patents